A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Heron Therapeutics

ClinicalTrials.gov Identifier:

NCT01416259

First received: August 10, 2011

Last updated: October 24, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2011
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)